CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kexing Biopharm Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kexing Biopharm Co Ltd
Mingshui Development Zone, Zhangqiu City
Phone: +86 75586967773p:+86 75586967773 JI'NAN, SDG  250200  China Ticker: 688136688136

Business Summary
Kexing Biopharm Co Ltd, formerly Shan Dong Kexing Bioproducts Co Ltd, is a China-based company principally involved in the research and development, manufacturing and sales of recombinant protein drugs and microecological preparations. Its products are the recombinant protein therapeutics 'Recombinant Human Erythropoietin', 'Recombinant Human Interferon a1b and Recombinant Human Granulocyte Colony-stimulating Factor, as well as the microbiota agents Combined Clostridium Butyricum and Bifidobacterium, etc. The Company's products are used for the therapeutic fields of antiviral, hematology, oncology and immunology, and degenerative diseases

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board XueqinDeng 56 7/1/2019 7/1/2019
Chief Financial Officer, Secretary of the Board, Director XiaoqinWang 47 1/16/2024 7/1/2019
General Manager, Director YanqingZhao 41 7/1/2019 7/1/2019
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,407 (As of 12/31/2022)
Outstanding Shares: 199,198,650 (As of 12/14/2023)
Shareholders: 12,443
Stock Exchange: SHA
Fax Number: +86 75586967891


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024